Pharm Exec’s 21st Annual Pipeline Report examines emerging drug development classes, treatment modalities, and expansion ...

Pharm Exec’s 21st Annual Pipeline Report examines emerging drug development classes, treatment modalities, and expansion pursuits in five therapeutic settings ripe for next-gen innovation.

Neurocrine Biosciences, Inc. leverages a strong cash position and a neuropsychiatry pipeline to drive long-term commercial ...

A miniaturized radar chip, developed by researchers at Science Tokyo, advances Integrated Sensing and Communication for Beyond 5G and 6G systems. Measuring just 0.24 mm2 and consuming only 9.8 mW, the ...

New disease-modifying agents are being evaluated in the clinic that could change the course of treatment for Alzheimer’s disease patients. Regulated industries like pharmaceuticals, biotech, and ...

Programmed cell death (PCD) stands at the forefront of innovation in experimental pharmacology and drug discovery, providing fundamental insights into ...

A team of New York University researchers announced in early February 2026 that they had created “levitating” time crystals, tiny particles suspended by sound waves that appear to defy Newton’s third ...

U.S. Air Force is intensifying efforts to protect its most vulnerable yet indispensable aircraft — aerial refueling tankers and heavy airlifters — by exploring a new class of “kinetic” self-defense ...

Stearns and Poletti present a technically impressive study that aims to uncover a deeper understanding of microsaccade function: their role in perceptual modulation and the associated temporal ...

Citi's 2026 Virtual Oncology Leadership Summit February 18, 2026 1:00 PM ESTCompany ParticipantsJoshua Bleharski - ...

BESTOW Phase II: The study did not meet its primary kidney-function endpoint but met the non-inferiority margin for the widely accepted composite endpoint (biopsy-proven rejection plus patient/graft ...